Find Natriuretic Peptide, Brain manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

32 RELATED EXCIPIENT COMPANIES

63EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 189032-40-4, Unii-el5u85ukd2, Nesiritide citrate [usan], El5u85ukd2, Natriuretic factor-32 (human brain clone lambdahbnp57), 2-hydroxy-1,2,3-propanetricarboxylate (salt), Brain natriuretic peptide-32 (human), 2-hydroxy-1,2,3-propanetricarboxylate (salt)
Molecular Formula
C149H252N50O49S4
Molecular Weight
3656.2  g/mol
InChI Key
OVGROODTNJWFAQ-INJFIXSDSA-N

Natriuretic Peptide, Brain
1 2D Structure

Natriuretic Peptide, Brain

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(4R,10S,16S,19S,22S,25S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31,43-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,19,22,25-tetrakis(hydroxymethyl)-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid;2-hydroxypropane-1,2,3-tricarboxylic acid
2.1.2 InChI
InChI=1S/C143H244N50O42S4.C6H8O7/c1-13-76(10)112-137(232)189-99(68-199)131(226)188-98(67-198)130(225)187-97(66-197)129(224)186-96(65-196)117(212)166-59-105(202)169-90(52-72(2)3)114(209)163-61-107(204)171-100(132(227)177-83(32-19-22-44-146)124(219)190-111(75(8)9)136(231)184-91(53-73(4)5)127(222)175-84(34-24-46-159-141(151)152)121(216)174-85(35-25-47-160-142(153)154)122(217)185-94(139(234)235)55-78-57-157-71-167-78)69-238-239-70-101(172-108(205)62-165-116(211)95(64-195)170-106(203)60-162-113(208)87(38-39-103(148)200)181-135(230)110(74(6)7)191-126(221)89(41-51-237-12)179-120(215)82(31-18-21-43-145)180-134(229)102-37-27-49-193(102)138(233)79(147)63-194)133(228)182-92(54-77-28-15-14-16-29-77)115(210)164-58-104(201)168-80(33-23-45-158-140(149)150)118(213)173-81(30-17-20-42-144)119(214)178-88(40-50-236-11)123(218)183-93(56-109(206)207)128(223)176-86(125(220)192-112)36-26-48-161-143(155)156;7-3(8)1-6(13,5(11)12)2-4(9)10/h14-16,28-29,57,71-76,79-102,110-112,194-199H,13,17-27,30-56,58-70,144-147H2,1-12H3,(H2,148,200)(H,157,167)(H,162,208)(H,163,209)(H,164,210)(H,165,211)(H,166,212)(H,168,201)(H,169,202)(H,170,203)(H,171,204)(H,172,205)(H,173,213)(H,174,216)(H,175,222)(H,176,223)(H,177,227)(H,178,214)(H,179,215)(H,180,229)(H,181,230)(H,182,228)(H,183,218)(H,184,231)(H,185,217)(H,186,224)(H,187,225)(H,188,226)(H,189,232)(H,190,219)(H,191,221)(H,192,220)(H,206,207)(H,234,235)(H4,149,150,158)(H4,151,152,159)(H4,153,154,160)(H4,155,156,161);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t76-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,110-,111-,112-;/m0./s1
2.1.3 InChI Key
OVGROODTNJWFAQ-INJFIXSDSA-N
2.1.4 Canonical SMILES
CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CN=CN4)C(=O)O)CC(C)C)CO)CO)CO)CO.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
2.1.5 Isomeric SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CO)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC4=CN=CN4)C(=O)O)CC(C)C)CO)CO)CO)CO.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 189032-40-4

2. Unii-el5u85ukd2

3. Nesiritide Citrate [usan]

4. El5u85ukd2

5. Natriuretic Factor-32 (human Brain Clone Lambdahbnp57), 2-hydroxy-1,2,3-propanetricarboxylate (salt)

6. Brain Natriuretic Peptide-32 (human), 2-hydroxy-1,2,3-propanetricarboxylate (salt)

7. L-seryl-l-prolyl-l-lysyl-l-methionyl-l-valyl-l-glutaminylglycyl-l-serylglycyl-l-cysteinyl-l-phenylalanylglycyl-l-arginyl-l-lysyl-l-methionyl-l-aspartyl-l-arginyl-l-isoleucyl-l-seryl-l-seryl-l-seryl-l-serylglycyl-l-leucylglycyl-l-cysteinyl-l-lysyl-l-valyl-l-leucyl-l-arginyl-l-arginyl-l-histidine Cyclic(10-26) - Disulfide Citrate (salt)

2.3 Create Date
2012-03-21
3 Chemical and Physical Properties
Molecular Weight 3656.2 g/mol
Molecular Formula C149H252N50O49S4
Hydrogen Bond Donor Count60
Hydrogen Bond Acceptor Count62
Rotatable Bond Count96
Exact Mass3654.7680641 g/mol
Monoisotopic Mass3653.7647093 g/mol
Topological Polar Surface Area1750 Ų
Heavy Atom Count252
Formal Charge0
Complexity7970
Isotope Atom Count0
Defined Atom Stereocenter Count28
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Direct Compression

read-more
read-more

Taste Masking

read-more
read-more

Parenteral

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

API Stability Enhancers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Natriuretic Peptide, Brain Manufacturers

A Natriuretic Peptide, Brain manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Natriuretic Peptide, Brain, including repackagers and relabelers. The FDA regulates Natriuretic Peptide, Brain manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Natriuretic Peptide, Brain API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Natriuretic Peptide, Brain manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Natriuretic Peptide, Brain Suppliers

A Natriuretic Peptide, Brain supplier is an individual or a company that provides Natriuretic Peptide, Brain active pharmaceutical ingredient (API) or Natriuretic Peptide, Brain finished formulations upon request. The Natriuretic Peptide, Brain suppliers may include Natriuretic Peptide, Brain API manufacturers, exporters, distributors and traders.

click here to find a list of Natriuretic Peptide, Brain suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Natriuretic Peptide, Brain USDMF

A Natriuretic Peptide, Brain DMF (Drug Master File) is a document detailing the whole manufacturing process of Natriuretic Peptide, Brain active pharmaceutical ingredient (API) in detail. Different forms of Natriuretic Peptide, Brain DMFs exist exist since differing nations have different regulations, such as Natriuretic Peptide, Brain USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Natriuretic Peptide, Brain DMF submitted to regulatory agencies in the US is known as a USDMF. Natriuretic Peptide, Brain USDMF includes data on Natriuretic Peptide, Brain's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Natriuretic Peptide, Brain USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Natriuretic Peptide, Brain suppliers with USDMF on PharmaCompass.

Natriuretic Peptide, Brain NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Natriuretic Peptide, Brain as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Natriuretic Peptide, Brain API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Natriuretic Peptide, Brain as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Natriuretic Peptide, Brain and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Natriuretic Peptide, Brain NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Natriuretic Peptide, Brain suppliers with NDC on PharmaCompass.

Natriuretic Peptide, Brain GMP

Natriuretic Peptide, Brain Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Natriuretic Peptide, Brain GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Natriuretic Peptide, Brain GMP manufacturer or Natriuretic Peptide, Brain GMP API supplier for your needs.

Natriuretic Peptide, Brain CoA

A Natriuretic Peptide, Brain CoA (Certificate of Analysis) is a formal document that attests to Natriuretic Peptide, Brain's compliance with Natriuretic Peptide, Brain specifications and serves as a tool for batch-level quality control.

Natriuretic Peptide, Brain CoA mostly includes findings from lab analyses of a specific batch. For each Natriuretic Peptide, Brain CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Natriuretic Peptide, Brain may be tested according to a variety of international standards, such as European Pharmacopoeia (Natriuretic Peptide, Brain EP), Natriuretic Peptide, Brain JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Natriuretic Peptide, Brain USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty